Abstract

Human immunodeficiency virus (HIV) infections lead to a progressive loss of CD4 T cells primarily via the process of apoptosis. With a limited number of infected cells and vastly disproportionate apoptosis in HIV infected patients, it is believed that apoptosis of uninfected bystander cells plays a significant role in this process. Disease progression in HIV infected individuals is highly variable suggesting that both host and viral factors may influence HIV mediated apoptosis. Amongst the viral factors, the role of Envelope (Env) glycoprotein in bystander apoptosis is well documented. Recent evidence on the variability in apoptosis induction by primary patient derived Envs underscores the role of Env glycoprotein in HIV disease. Amongst the host factors, the role of C-C Chemokine Receptor type 5 (CCR5), a coreceptor for HIV Env, is also becoming increasingly evident. Polymorphisms in the CCR5 gene and promoter affect CCR5 cell surface expression and correlate with both apoptosis and CD4 loss. Finally, chronic immune activation in HIV infections induces multiple defects in the immune system and has recently been shown to accelerate HIV Env mediated CD4 apoptosis. Consequently, those factors that affect CCR5 expression and/or immune activation in turn indirectly regulate HIV mediated apoptosis making this phenomenon both complex and multifactorial. This review explores the complex role of various host and viral factors in determining HIV mediated bystander apoptosis.

Highlights

  • Human immunodeficiency virus (HIV) infection in humans leads to a progressive loss of CD4 T cells culminating in immunodeficiency

  • Another member of the tumor necrosis factor (TNF) family that has been implicated in HIV induced bystander apoptosis in vivo is TRAIL/Apo2 Ligand (APO2L) as T cells from HIV+ patients are more prone to TRAIL mediated cell death [91]

  • Recent studies by our group have found that activation of peripheral blood mononuclear cells (PBMCs) in vitro enhances the susceptibility of CD4 T cells to HIV-1 Env mediated bystander apoptosis and alters CD4:CD8 ratio similar to that observed in HIV infections [10]

Read more

Summary

Introduction

Human immunodeficiency virus (HIV) infection in humans leads to a progressive loss of CD4 T cells culminating in immunodeficiency. Support for a role of apoptosis in CD4 T cell loss in HIV infections comes from simian immunodeficiency virus (SIV) infections in non-human primates. High levels of viremia in natural SIV infections fails to induce CD4 apoptosis and subsequent CD4 loss [4] These observations argue against a role of viremia in HIV mediated apoptosis. Recent evidence from our lab demonstrates that a number of immunopathological features of HIV infection including CD4 apoptosis correlates with viremia [10]. This process is complex and cases where viremia fails to mediate CD4 apoptosis/decline; other host and viral factors are likely involved. In pathogenic SIV models [5,6] and HIV infection in humanized mouse models [26,29], apoptosis in bystander cells has been observed

Env Glycoprotein
Mechanism of HIV Env-Mediated Apoptosis
HIV Env Glycoprotein Variability and Evolution
Signaling via HIV Env Glycoprotein
Targeting HIV gp41 Can Alter Bystander Apoptosis
Effects of HIV Env on Cell Types Other Than CD4 T Cells
CCR5: Role of CCR5 in HIV Disease
CCR5 Polymorphisms
CCR5 Env Interaction in HIV-Mediated Apoptosis
CCR5 in Primate Models of SIV Infection
Immune Activation in HIV Disease
Viremia and Immune Activation
Toll-Like Receptors in Immune Activation
Immune Activation and Apoptosis
Role of Autophagy in HIV-Mediated Cell Death
Role of Pyroptosis in HIV-Mediated Cell Death
Model of HIV-Mediated Bystander Apoptosis
Host and Viral Factors
Host and Viral Factors Determining Differential CD4 Loss in HIV Infections
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call